86 related articles for article (PubMed ID: 11490204)
1. In vitro and in vivo activity of new rhodium (III) complexes against Leishmania donovani.
Rodriguez-Cabezas MN; Mesa-Valle CM; Azzouz S; Moraleda-Lindez V; Craciunescu D; Gutierrez-Rios MT; De Frutos MI; Osuna A
Pharmacology; 2001; 63(2):112-9. PubMed ID: 11490204
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activity of two Pt(IV) salts against leishmania donovani.
Mesa-Valle CM; Rodriguez-Cabezas MN; Moraleda-Lindez V; Craciunescu D; Sanchez-Moreno M; Osuna A
Pharmacology; 1998 Sep; 57(3):160-72. PubMed ID: 9691236
[TBL] [Abstract][Full Text] [Related]
3. The activity of platinum, iridium and rhodium drug complexes against Leishmania donovani.
Croft SL; Neal RA; Craciunescu DG; Certad-Fombona G
Trop Med Parasitol; 1992 Mar; 43(1):24-8. PubMed ID: 1598504
[TBL] [Abstract][Full Text] [Related]
4. Action of new organometallic complexes against Leishmania donovani.
Mesa-Valle CM; Moraleda V; Lazuen J; Craciunescu D; Osuna A
J Antimicrob Chemother; 1997 Jul; 40(1):47-57. PubMed ID: 9249204
[TBL] [Abstract][Full Text] [Related]
5. In vitro action of new organometallic compounds against Trypanosomatidae protozoa.
Mesa-Valle CM; Moraleda-Lindez V; Craciunescu D; Alonso MP; Osuna A
Arzneimittelforschung; 1993 Sep; 43(9):1010-3. PubMed ID: 8240449
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activities of three acridine thioethers against Leishmania donovani.
Mesa C; Rodriguez-Cabezas N; Castilla JJ; Moraleda-Lindez V; Barbe J; Sanchez-Moreno M; Osuna A
Pharmacology; 2002 May; 65(2):74-82. PubMed ID: 11937777
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of chalcones as potential antileishmanial agents.
Gupta S; Shivahare R; Korthikunta V; Singh R; Gupta S; Tadigoppula N
Eur J Med Chem; 2014 Jun; 81():359-66. PubMed ID: 24858541
[TBL] [Abstract][Full Text] [Related]
8. Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis.
Kansal S; Tandon R; Dwivedi P; Misra P; Verma PR; Dube A; Mishra PR
J Antimicrob Chemother; 2012 Nov; 67(11):2650-60. PubMed ID: 22872448
[TBL] [Abstract][Full Text] [Related]
9. Effect of ureastibamine on Leishmania donovani amastigote.
Ghosh AK; Mukerji K; Ghosh DK
Indian J Med Res; 1990 May; 91():208-13. PubMed ID: 2397943
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo leishmanicidal activity of Dysoxylum binectariferum and its fractions against Leishmania donovani.
Lakshmi V; Pandey K; Kapil A; Singh N; Samant M; Dube A
Phytomedicine; 2007 Jan; 14(1):36-42. PubMed ID: 17190644
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
Gopinath VS; Pinjari J; Dere RT; Verma A; Vishwakarma P; Shivahare R; Moger M; Kumar Goud PS; Ramanathan V; Bose P; Rao MV; Gupta S; Puri SK; Launay D; Martin D
Eur J Med Chem; 2013 Nov; 69():527-36. PubMed ID: 24095747
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
[TBL] [Abstract][Full Text] [Related]
14. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
Kaur J; Sundar S; Singh N
J Antimicrob Chemother; 2010 Aug; 65(8):1742-8. PubMed ID: 20519355
[TBL] [Abstract][Full Text] [Related]
15. Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani.
Carter KC; Mullen AB; Sundar S; Kenney RT
Antimicrob Agents Chemother; 2001 Dec; 45(12):3555-9. PubMed ID: 11709339
[TBL] [Abstract][Full Text] [Related]
16. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
Dömötör O; Aicher S; Schmidlehner M; Novak MS; Roller A; Jakupec MA; Kandioller W; Hartinger CG; Keppler BK; Enyedy ÉA
J Inorg Biochem; 2014 May; 134():57-65. PubMed ID: 24556426
[TBL] [Abstract][Full Text] [Related]
17. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.
Sinha R; Roychoudhury J; Palit P; Ali N
Antimicrob Agents Chemother; 2015 Jan; 59(1):344-55. PubMed ID: 25367907
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of leishmanicidal activity of human macrophages against Leishmania major and Leishmania donovani infection using recombinant human granulocyte macrophage colony stimulating factor.
Al-Zamel F; Al-Shammary FJ; El-Shewemi S; Soliman R
Zentralbl Bakteriol; 1996 Sep; 285(1):92-105. PubMed ID: 8946701
[TBL] [Abstract][Full Text] [Related]
19. Antileishmanial potential of a marine sponge, Haliclona exigua (Kirkpatrick) against experimental visceral leishmaniasis.
Dube A; Singh N; Saxena A; Lakshmi V
Parasitol Res; 2007 Jul; 101(2):317-24. PubMed ID: 17294216
[TBL] [Abstract][Full Text] [Related]
20. Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani.
Dikhit MR; Purkait B; Singh R; Sahoo BR; Kumar A; Kar RK; Ansari MY; Saini S; Abhishek K; Sahoo GC; Das S; Das P
Drug Des Devel Ther; 2016; 10():1753-61. PubMed ID: 27307706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
